HR 2482
116th Congress
House
Crime and Law Enforcement
Administrative law and regulatory procedures
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Government information and archives
Health care coverage and access
Prescription drugs
Mainstreaming Addiction Treatment Act of 2019
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 31, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
May 3, 2019
Referred to the Subcommittee on Health.
May 2, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 2, 2019
Introduced in House
Plain-English summary
Mainstreaming Addiction Treatment Act of 2019
This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).
Further, the bill directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.